Ş. ATAMAN Et Al. , "THE RELATIONSHIP BETWEEN IMMUNOGENICITY, DISEASE ACTIVITY AND AUTOANTIBODY DEVELOPMENT IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH ANTI-TNF AGENTS," 15th Annual European Congress of Rheumatology (EULAR) , Paris, France, pp.482, 2014
ATAMAN, Ş. Et Al. 2014. THE RELATIONSHIP BETWEEN IMMUNOGENICITY, DISEASE ACTIVITY AND AUTOANTIBODY DEVELOPMENT IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH ANTI-TNF AGENTS. 15th Annual European Congress of Rheumatology (EULAR) , (Paris, France), 482.
ATAMAN, Ş., Soltanalizade, R., Tutkak, H., Oztuna, D., Ozdemirel, E., & Surmeli, Z. S., (2014). THE RELATIONSHIP BETWEEN IMMUNOGENICITY, DISEASE ACTIVITY AND AUTOANTIBODY DEVELOPMENT IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH ANTI-TNF AGENTS . 15th Annual European Congress of Rheumatology (EULAR) (pp.482). Paris, France
ATAMAN, ŞEBNEM Et Al. "THE RELATIONSHIP BETWEEN IMMUNOGENICITY, DISEASE ACTIVITY AND AUTOANTIBODY DEVELOPMENT IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH ANTI-TNF AGENTS," 15th Annual European Congress of Rheumatology (EULAR), Paris, France, 2014
ATAMAN, ŞEBNEM Et Al. "THE RELATIONSHIP BETWEEN IMMUNOGENICITY, DISEASE ACTIVITY AND AUTOANTIBODY DEVELOPMENT IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH ANTI-TNF AGENTS." 15th Annual European Congress of Rheumatology (EULAR) , Paris, France, pp.482, 2014
ATAMAN, Ş. Et Al. (2014) . "THE RELATIONSHIP BETWEEN IMMUNOGENICITY, DISEASE ACTIVITY AND AUTOANTIBODY DEVELOPMENT IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH ANTI-TNF AGENTS." 15th Annual European Congress of Rheumatology (EULAR) , Paris, France, p.482.
@conferencepaper{conferencepaper, author={ŞEBNEM ATAMAN Et Al. }, title={THE RELATIONSHIP BETWEEN IMMUNOGENICITY, DISEASE ACTIVITY AND AUTOANTIBODY DEVELOPMENT IN PATIENTS WITH RHEUMATIC DISEASES TREATED WITH ANTI-TNF AGENTS}, congress name={15th Annual European Congress of Rheumatology (EULAR)}, city={Paris}, country={France}, year={2014}, pages={482} }